UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

Oncology, 2007-01, Vol.72 (5-6), p.397-402

2007

Volltextzugriff (PDF)

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

Annals of oncology, 2012-12, Vol.23 (12), p.3137-3143

2012

Volltextzugriff (PDF)

Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry

Annals of oncology, 2012-02, Vol.23 (2), p.395-401

2012

Volltextzugriff (PDF)

Expression Levels of Transcribed Ultraconserved Regions uc.73 and uc.388 Are Altered in Colorectal Cancer

Oncology, 2012-01, Vol.82 (2), p.114-118

2012

Volltextzugriff (PDF)

PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii114-ii115

2016

Volltextzugriff (PDF)

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients

Neoplasma, 2010, Vol.57 (3), p.264

2010

Volltextzugriff (PDF)

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX

Oncology letters, 2017-07, Vol.14 (1), p.743-750

2017

Volltextzugriff (PDF)

188 Efficacy and Safety of Lapatinib Treatment in Trastuzumab Pretreated Patients with HER2 Positive Metastatic Breast Cancer – An Analysis of IntERB Registry in the Czech Republic

European journal of cancer (1990), 2012-03, Vol.48, p.S94-S95

2012

Volltextzugriff (PDF)

185 Combined proteomics and transcriptomics identifies carboxypeptidase B1 and NF-κB associated proteins as putative biomarkers of metastasis in low grade breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S24-S25

2015

Volltextzugriff (PDF)

Cancer incidence and mortality in the Czech Republic

Klinická onkologie, 2014, Vol.27 (6), p.406-423

2014

Volltextzugriff (PDF)

Significant overexpression of Hsp110 gene during colorectal cancer progression

Oncology reports, 2009-05, Vol.21 (5), p.1235-1241

2009

Volltextzugriff (PDF)

Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry

Targeted oncology, 2015-09, Vol.10 (3), p.385-392

2015

Volltextzugriff (PDF)

41P Predicting response to checkpoint inhibitors using complex molecular characteristics and immunoprofiling in solid tumours

Annals of oncology, 2021-12, Vol.32, p.S1389

2021

Volltextzugriff (PDF)

Cancer incidence and mortality in the Czech Republic

Klinická onkologie, 2010, Vol.23 (5), p.311-324

2010

Volltextzugriff (PDF)

1044P Predicting response to checkpoint inhibitors using complex molecular characteristic and immunoprofiling in solid tumours

Annals of oncology, 2020-09, Vol.31, p.S716-S716

2020

Volltextzugriff (PDF)

Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours

Bratislavské lékarské listy, 2015, Vol.116 (4), p.218-221

2015

Volltextzugriff (PDF)

MicroRNA involvement in glioblastoma pathogenesis

Biochemical and biophysical research communications, 2009-08, Vol.386 (1), p.1-5

2009

Volltextzugriff (PDF)

Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic

Neoplasma, 2008, Vol.55 (4), p.356

2008

Volltextzugriff (PDF)

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

Journal of clinical oncology, 2006-02, Vol.24 (4), p.571-578

2006

Volltextzugriff (PDF)

167 MicroRNA-34 family in triple-negative/basal-like breast cancer

European journal of cancer supplements, 2010, Vol.8 (5), p.44-44

2010

Volltextzugriff (PDF)

168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry

Annals of oncology, 2016-12, Vol.27, p.ix53-ix53

2016

Volltextzugriff (PDF)

Bile duct malignancies

Klinická onkologie, 2010, Vol.23 (4), p.231-241

2010

Volltextzugriff (PDF)

PD-033 Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

Annals of oncology, 2016-06, Vol.27, p.ii114

2016

Volltextzugriff (PDF)

852 Prediction of response of locally advanced rectal adenocarcinomas to neoadjuvant chemoradiotherapy by microRNA profiling

European journal of cancer supplements, 2010, Vol.8 (5), p.215-215

2010

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(117)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(76)
Female
(43)
Male
(35)
Middle Aged
(34)
Adult
(33)
Aged
(26)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Oncology
(18)
Prognosis
(12)
Czech Republic - Epidemiology
(11)
Disease-Free Survival
(11)
Aged, 80 And Over
(9)
Hematology, Oncology And Palliative Medicine
(9)
Retrospective Studies
(9)
Antineoplastic Agents - Therapeutic Use
(8)
Chemotherapy, Adjuvant
(8)
Combined Modality Therapy
(8)
Registries
(8)
Treatment Outcome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study

Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry

Expression Levels of Transcribed Ultraconserved Regions uc.73 and uc.388 Are Altered in Colorectal Cancer

PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX

188 Efficacy and Safety of Lapatinib Treatment in Trastuzumab Pretreated Patients with HER2 Positive Metastatic Breast Cancer – An Analysis of IntERB Registry in the Czech Republic

185 Combined proteomics and transcriptomics identifies carboxypeptidase B1 and NF-κB associated proteins as putative biomarkers of metastasis in low grade breast cancer

Cancer incidence and mortality in the Czech Republic

Significant overexpression of Hsp110 gene during colorectal cancer progression

Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry

41P Predicting response to checkpoint inhibitors using complex molecular characteristics and immunoprofiling in solid tumours

Cancer incidence and mortality in the Czech Republic

1044P Predicting response to checkpoint inhibitors using complex molecular characteristic and immunoprofiling in solid tumours

Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours

MicroRNA involvement in glioblastoma pathogenesis

Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

167 MicroRNA-34 family in triple-negative/basal-like breast cancer

168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry

168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry

Bile duct malignancies

PD-033 Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

852 Prediction of response of locally advanced rectal adenocarcinomas to neoadjuvant chemoradiotherapy by microRNA profiling

Suchergebnisse filtern